EXO1 and lung carcinoma: In agreement with published genome-wide CRISPR screens in lung cancer cell lines with an ATM kinase inhibitor25, we confirmed the sensitivity of eHAP EXO1 KO cell lines to an ATM kinase inhibitor (Supplementary Fig. 2g).